Why the study?
PGF2α may have therapeutic utility as a non-catecholaminergic inotrope, but its effect on hypertrophied hearts had not previously been examined.
Does Prostaglandin F2α improve left ventricular developed pressure in isolated perfused rat hearts with right ventricular hypertrophy?
Does Prostaglandin F2α improve left ventricular developed pressure in isolated perfused rat hearts with right ventricular hypertrophy?
Answers are grounded in this paper and cite their sources.
PGF2α provides positive inotropic support without increasing heart rate in rat hearts, but may cause arrhythmias in the setting of right ventricular hypertrophy at a dose of 0.3 μM.
BACKGROUND: Prostaglandin F2α (PGF2α) has a positively inotropic effect on right ventricular (RV) trabeculae from healthy adult rat hearts, and may therefore be therapeutically useful as a non-catecholaminergic inotrope. These provide additional contractile support for the heart without the added energetic demand of increased heart rate, and are also suitable for patients with reduced β adrenergic receptor (β-AR) responsiveness, or impaired mitochondrial energy supply. However, the response of hypertrophied rat hearts to PGF2α has not previously been examined. Our aim was therefore to determine the effect of PGF2α on isolated perfused rat hearts with RV hypertrophy following induction of pulmonary artery hypertension. METHODS: of monocrotaline (MCT, n = 10) or sterile saline as control (CON, n = 11). Four weeks post injection; hearts were isolated and Langendorff-perfused in sinus rhythm. Measurement of left ventricular (LV) pressure and the electrocardiogram were made and the response to 0.3 μM PGF2α was determined. RESULTS: PGF2α increased LV developed pressure in CON and in 60% MCT hearts, with no change in heart rate. However, 40% of MCT hearts developed arrhythmias during the peak inotropic response. For comparison, the response to 0.03 μM isoproterenol (ISO) was also investigated. Peak LV pressure developed sooner in response to ISO compared to PGF2α in both rat groups, although the inotropic response to ISO was reduced in MCT hearts. Analysis of fixed ventricular tissue confirmed that only RV myocytes were hypertrophied in MCT hearts. Our study showed that PGF2α was positively inotropic for healthy hearts, but found it generated arrhythmias in 40% of MCT hearts at the dose investigated. However, a more physiological dose of PGF2α may be a useful alternative without the added energetic cost of catecholaminergic inotropes.
No takes yet. Share an insight, caveat, or question.
Krstic et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: